HomeAI · summaries
Storia in 3 fonti
Pancreatic cancer: New drug extends lives but isn't a cure
The newly developed treatment daraxonrasib can double the years left to live for patients with pancreatic cancer — but it doesn't cure the disease and only works if the cancer is treated early.
Confronto fonti
3 prospettive sulla stessa storiaTimeline cronologica
- ·
eltiempo.com
Nuevo tratamiento para el cáncer de páncreas logra duplicar la supervivencia de pacientes con enfermedad avanzada
Los pacientes que recibieron daraxonrasib alcanzaron una supervivencia media de 13,2 meses, frente a los 6,7 meses de quienes recibieron quimioterapia
- ·
forbes.com
In Fight Against Pancreatic Cancer, Daraxonrasib Is Rare Sign Of Hope
The death rate in the group treated with daraxonrasib was 60% lower than those on chemotherapy. This is hailed as a major advance against metastatic pancreatic cancer.
